The Netherlands: drug-related information and data
The Netherlands
Our partner in The Netherlands
Trimbos-instituut (Netherlands Institute of Public Health and Addiction)
Da Costakade 45
PO Box 725
NL-3500 AS Utrecht
Tel. +31 302971186
Fax +31 302971187
Head of focal point: Mr Franz Trautmann
The national focal point in the Netherlands is integrated within the National Drug Monitor, established in 1999 by the Minister of Health, Welfare and Sport in order to evaluate and review registration and survey research data at national level, and to report these data to the Lower Chamber of Parliament, concerned ministries and other stakeholders inside and outside the country. The NFP is part of the Drug Monitoring Department of the Trimbos Institute, the national research institute for mental health care, addiction care and social work in the Netherlands, which is tasked with informing policymakers and politicians about the mental health issues that concern the Dutch population.E-mail addresses have been inserted in a way discouraging spam. Please replace [a] by @ before actually using any of the e-mail addresses.
Country situation summaries are written with the general reader in mind and provide short, mainly text-based analyses of national drug situations.
Key data sheets provide an at-a-glance statistical view of the drug situation by country and cover areas including prevalence, problem drug use, infectious diseases, deaths, and more.
Country barometers provide a graphical representation of drug use prevalence data for each country, showing its position relative to other countries by population and drug.
What are countries in Europe doing to prevent illicit drug use? 'Prevention profiles' attempts to answer this question using interactive maps and data charts based on expert appraisals.
Legal profiles describe national drug-related legislation in a standardised, comparable format. Topics covered include possession, trafficking, classification, prosecution, prevention, treatment, among others.
This resource provides access to the current national strategies and action plans for each country as well as a brief description of recent and ongoing work in the area.
Each treatment profile provides information on the national context, treatment registries and monitoring systems, treatment demand, availability of treatment services as well as references and resources.
Each overview describes: the national context; references and resources; key responses for preventing and reducing drug-related infectious diseases and; drug-related deaths and drug-related harms in recreational settings.
These data sheets on drug-related public expenditure cover 30 countries and examine how much countries spend on drug-related activities, whether there are specific budgets allocated to drug policy documents, and how drug-related expenditure has evolved over time.
National reports draw an overall picture of the drug phenomenon at national level. The data is an important resource, among others for the compilation of the EMCDDA's Annual report.
National drug related research provides information by country in the following areas: main funding frameworks, research institutions, scientific journals, websites, main studies conducted and articles published.
